Adams Wealth Management

Position in BMY — Bristol Myers Squibb Co

CIK 1803084 LOGAN, UT

Position in BMY

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$810,425

+$139,212 QoQ

Shares Held

14,065

+27.1% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.53%

of 13F equity value

Holder Rank

#1,281

of 2,506 holders

Holding Since

Sep 2020

6 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Adams Wealth Management holds $3,392,754 across 6 Drug Manufacturers - General names. BMY ranks #2 (23.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GILD	Gilead Sciences, Inc.	6,766	$854,816
2	BMY	Bristol Myers Squibb Co This page	14,065	$810,425
3	ABBV	AbbVie Inc.	3,177	$799,460
4	LLY	ELI LILLY & Co	328	$393,413
5	PFE	Pfizer Inc	11,690	$281,495
6	MRK	Merck & Co., Inc.	1,970	$253,145

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$810,425	14,065	+27.1%	Shares	Other	2026-08-10
2026-03-31	$671,213	11,067	+5.1%	Shares	Other	2026-05-12
2025-12-31	$567,880	10,528	-6.3%	Shares	Sole	2026-02-18
2025-09-30	$506,653	11,234	-5.7%	Shares	Sole	2025-11-14
2025-06-30	$551,499	11,914	+477.8%	Shares	Sole	2025-09-25
2020-09-30	$124,317	2,062	—	Shares	Sole	2020-11-12
No filing history on record for this holder in this stock.